Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Coronary Syndrome
Antiplatelet therapy has an essential role in treating acute coronary syndromes
February 20th, 2005
A recent report on the role of antiplatelet therapy in cardiovascular disease focused on acute coronary syndromes. According to the report from the United States, "The acute coronary syndromes (ACS), consisting of ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable angina, remain a leading cause of death in the United States. Through the process of atherothrombosis, underlying atherosclerosis can progress to an acute ischemic coronary event. This disease mechanism is also common to ischemic stroke and peripheral arterial disease." J.J. Cavendish and colleagues of the U.S. Navy continued, "As ACS is a heterogeneous...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
